Study Elesclomol Sodium in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT01280786 · UNKNOWN
Trial details
- NCT number
- NCT01280786
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2014-06-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.